Cargando…
Intranasal Administration of Forskolin and Noopept Reverses Parkinsonian Pathology in PINK1 Knockout Rats
Parkinson’s Disease (PD) is a brain-degenerative disorder characterized by a progressive loss of midbrain dopamine neurons. Current standard-of-care includes oral administration of Levodopa to address motor symptoms, but this treatment is not disease-modifying. A reduction in Protein Kinase A (PKA)...
Autores principales: | Dagda, Ruben K., Dagda, Raul Y., Vazquez-Mayorga, Emmanuel, Martinez, Bridget, Gallahue, Aine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820624/ https://www.ncbi.nlm.nih.gov/pubmed/36614135 http://dx.doi.org/10.3390/ijms24010690 |
Ejemplares similares
-
Intraperitoneal Administration of Forskolin Reverses Motor Symptoms and Loss of Midbrain Dopamine Neurons in PINK1 Knockout Rats
por: Vazquez-Mayorga, Emmanuel, et al.
Publicado: (2022) -
How Parkinsonian Toxins Dysregulate the Autophagy Machinery
por: Dagda, Ruben K., et al.
Publicado: (2013) -
Role of Cleaved PINK1 in Neuronal Development, Synaptogenesis, and Plasticity: Implications for Parkinson’s Disease
por: Soman, Smijin K., et al.
Publicado: (2021) -
Novel Redox-Dependent Esterase Activity (EC 3.1.1.2) for DJ-1: Implications for Parkinson’s Disease
por: Vázquez-Mayorga, Emmanuel, et al.
Publicado: (2016) -
Psychological distress and lack of PINK1 promote bioenergetics alterations in peripheral blood mononuclear cells
por: Grigoruţă, Mariana, et al.
Publicado: (2020)